0 of 3 questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 3 questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
You must score 0% to continue. Please click the link below to re-take the quiz
1. How confident are you in the management of patients with urothelial carcinoma (UC) in your practice?
2. Which treatment would you recommend for a patient with advanced UC who does not have FGFR 2/3 alterations but has progressed after cis-based chemo?
3. Enfortumab vedotin and sacituzumab govitecan both recently approved for 3L UC, belong to which class?